Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ENZON PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - ENZON PHARMACEUTICALS, INC. | v402704_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ENZON PHARMACEUTICALS, INC. | v402704_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - ENZON PHARMACEUTICALS, INC. | v402704_ex32-2.htm |
| EX-21.1 - EXHIBIT 21.1 - ENZON PHARMACEUTICALS, INC. | v402704_ex21-1.htm |
| EX-31.1 - EXHIBIT 31.1 - ENZON PHARMACEUTICALS, INC. | v402704_ex31-1.htm |
| 10-K - 10-K - ENZON PHARMACEUTICALS, INC. | v402704_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Enzon Pharmaceuticals, Inc. and Subsidiaries on Form S-3 (No. 333-137723) and Form S-8 (Nos. 333-174099, 333-140282,333-134453, 333-132467, 333-121468, 333-101898, 333-64110, and 333-18051) of our report dated March 5, 2015, on our audit of the consolidated financial statements as of December 31, 2014 and for each of the years in the two-year period ended December 31, 2014, which report is included in this Annual Report on Form 10-K.
/s/ EISNERAMPER LLP
Iselin, New Jersey
March 5, 2015